Combined Pharmacotherapy for Cannabis Dependency

• Status: Completed
• Trial end date: 2014-09-01

Summary

The purpose of this study is to see if Lofexidine in combination with Marinol is superior to placebo in achieving abstinence, reducing cannabis use and reducing withdrawal in cannabis-dependent patients seeking treatment for their marijuana use.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: New York State Psychiatric Institute
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Clonidine; Dronabinol; Lofexidine